Return to search

LifeMine Therapeutics pockets $175m Series

LifeMine Therapeutics Inc., a biopharmaceutical company, has secured $175 million in Series C financing.

LifeMine Therapeutics Inc., a biopharmaceutical company, has secured $175 million in Series C financing. Fidelity Management & Research Company led the round.

Source: Press Release